Keyphrases
Expression Pattern
100%
Oropharyngeal Squamous Cell Carcinoma (OPSCC)
100%
Radiomics
100%
Early Metabolic Response
100%
Recurrence-free Survival
40%
Metabolic
20%
Clinical Features
20%
Head-and-neck Cancer
20%
HPV Status
20%
Unsupervised Clustering
20%
Prognostic Value
20%
Tumor Volume
20%
N Stage
20%
Patient Cohort
10%
Prospective Clinical Trial
10%
Cancer Patients
10%
Therapeutic Response
10%
Cancer Tumor
10%
Site of Disease
10%
Primary Tumor
10%
Recurrent Disease
10%
Clinical Follow-up
10%
Positron Emission Tomography-computed Tomography (PET-CT)
10%
Potential Biomarkers
10%
Spatial Heterogeneity
10%
Cluster-based
10%
Supervised Learning
10%
Multivariable
10%
Overfitting
10%
Residual Disease
10%
Radiological Data
10%
Hyperparameter Tuning
10%
Imaging Characteristics
10%
T Stage
10%
Clustering Results
10%
Definitive Chemoradiation Therapy
10%
Therapy Strategy
10%
Kaplan-Meier Estimator
10%
Cox Proportional Hazards Modeling
10%
Prognostic Potential
10%
18F-FDG PET-CT
10%
Time Series Clustering
10%
Definitive Chemoradiation
10%
Cox Analysis
10%
Image Protocol
10%
Adaptive Therapy
10%
Metabolic Imaging
10%
PET Radiomics
10%
Data Clustering Algorithm
10%
Pharmacology, Toxicology and Pharmaceutical Science
Oropharynx Cancer
100%
Recurrence Free Survival
100%
Oropharynx Carcinoma
100%
Neoplasm
75%
Clinical Feature
50%
Recurrent Disease
50%
Head and Neck Cancer
50%
Chemoradiation Therapy
50%
Polyethylene Terephthalate
50%
Clinical Trial
25%
Biological Marker
25%
Minimal Residual Disease
25%
Primary Tumor
25%
Fluorodeoxyglucose F 18
25%
Diseases
25%
Medicine and Dentistry
Cancer
100%
Metabolism
100%
Radiomics
100%
Recurrence Free Survival
36%
Oropharynx Carcinoma
36%
Neoplasm
27%
Clinical Feature
18%
Recurrent Disease
18%
Head and Neck Cancer
18%
Clinical Trial
9%
Biological Marker
9%
Treatment Response
9%
Primary Tumor
9%
Minimal Residual Disease
9%
Positron Emission Tomography-Computed Tomography
9%
Chemoradiotherapy
9%
Chemoradiation Therapy
9%
Kaplan Meier Method
9%
Fluorodeoxyglucose F 18
9%
Polyethylene Terephthalate
9%
Diseases
9%
Neuroscience
Metabolic Pathway
100%
Positron Emission Tomography
50%
Fluorine-18
50%
Positron Emission Tomography-Computed Tomography
50%
Radiation Therapy
50%
Biochemistry, Genetics and Molecular Biology
Metabolic Pathway
100%
Radiomics
100%
Recurrence Free Survival
36%
Tumor Volume
18%
Clinical Trial
9%
Positron Emission Tomography-Computed Tomography
9%